Durect corporation reports fourth quarter and full year 2023 financial results and provides business update

- ongoing communication with fda to align on next steps for larsucosterol in alcohol-associated hepatitis - webcast of earnings call today, march 27th at 4:30 p.m. et cupertino, calif.
DRRX Ratings Summary
DRRX Quant Ranking